Similar articles for PMID: 21282741

Year	Number of Results
1985	2
1987	2
1988	1
1989	2
1993	1
1999	1
2003	1
2005	6
2006	6
2007	5
2008	13
2009	10
2010	9
2011	8
2012	3
2013	2
2014	3
2015	3
2016	5
2017	1
2021	0

1

Increased in vivo efficacy of lenalidomide by addition of piroctone olamine.

Kim Y, Alpmann P, Blaum-Feder S, Krämer S, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Kim Y, et al. In Vivo. 2011 Jan-Feb;25(1):99-103. In Vivo. 2011. PMID: 21282741

2

In vivo efficacy of griseofulvin against multiple myeloma.

Kim Y, Alpmann P, Blaum-Feder S, Krämer S, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Kim Y, et al. Leuk Res. 2011 Aug;35(8):1070-3. doi: 10.1016/j.leukres.2010.10.008. Epub 2010 Nov 26. Leuk Res. 2011. PMID: 21112630

3

Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.

Kim Y, Schmidt M, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Kim Y, et al. In Vivo. 2011 Nov-Dec;25(6):887-93. In Vivo. 2011. PMID: 22021681

4

Increased in vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid.

Schmidt M, Kim Y, Gast SM, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Schmidt M, et al. In Vivo. 2011 May-Jun;25(3):325-33. In Vivo. 2011. PMID: 21576405

5

In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma.

Kim Y, Gast SM, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Kim Y, et al. Leuk Res. 2012 May;36(5):598-600. doi: 10.1016/j.leukres.2012.01.025. Epub 2012 Mar 2. Leuk Res. 2012. PMID: 22386728

6

Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff.

Schmidt-Rose T, Braren S, Fölster H, Hillemann T, Oltrogge B, Philipp P, Weets G, Fey S. Schmidt-Rose T, et al. Int J Cosmet Sci. 2011 Jun;33(3):276-82. doi: 10.1111/j.1468-2494.2010.00623.x. Epub 2011 Jan 27. Int J Cosmet Sci. 2011. PMID: 21272039 Clinical Trial.

7

Lenalidomide and thalidomide: mechanisms of action--similarities and differences.

Anderson KC. Anderson KC. Semin Hematol. 2005 Oct;42(4 Suppl 4):S3-8. doi: 10.1053/j.seminhematol.2005.10.001. Semin Hematol. 2005. PMID: 16344099 Review.

8

Lenalidomide in multiple myeloma.

Thomas SK, Richards TA, Weber DM. Thomas SK, et al. Best Pract Res Clin Haematol. 2007 Dec;20(4):717-35. doi: 10.1016/j.beha.2007.09.002. Best Pract Res Clin Haematol. 2007. PMID: 18070715 Review.

9

[Anti-pityriasis activity of a line of products containing piroctone olamine].

Bartalini P, Bilenchi R, Dina F. Bartalini P, et al. G Ital Dermatol Venereol. 1987 Mar;122(3):XI-XIX. G Ital Dermatol Venereol. 1987. PMID: 3596640 Italian. No abstract available.

10

Lenalidomide mode of action: linking bench and clinical findings.

Davies F, Baz R. Davies F, et al. Blood Rev. 2010 Nov;24 Suppl 1:S13-9. doi: 10.1016/S0268-960X(10)70004-7. Blood Rev. 2010. PMID: 21126632 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed